-
Phase 1/Phase 2
-
-
18-65
-
17
-
Not Yet Recruiting
Not Yet Recruiting
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and the preliminary evidence of disease-modifying effect of BMS-986528 in participants with refractory, difficult-to-treat rheumatoid arthritis (RA).
Experimental: Cohort A1
Experimental: Cohort A2
Experimental: Cohort A3
Experimental: Cohort A4
Experimental: Cohort A5
Experimental: Cohort A6
Experimental: Cohort A7
Experimental: Cohort A8
Experimental: Cohort B1
Experimental: Cohort B2